AT
GH icon

Arden Trust’s Guardant Health GH Stock Holding History

Arden Trust’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,515
Closed -$404K – 265
2022
Q3 		$404K Sell
7,515
-132
-2% -$6.78K 0.1% 186
2022
Q2 		$309K Sell
7,647
-22
-0.3% -$1.09K 0.07% 217
2022
Q1 		$508K Sell
7,669
-652
-8% -$44.6K 0.1% 184
2021
Q4 		$832K Sell
8,321
-126
-1% -$13K 0.14% 147
2021
Q3 		$1.06M Buy
8,447
+121
+1% +$14.4K 0.18% 120
2021
Q2 		$1.03M Buy
8,326
+196
+2% +$26.4K 0.17% 129
2021
Q1 		$1.24M Sell
8,130
-646
-7% -$97.6K 0.21% 102
2020
Q4 		$1.13M Sell
8,776
-59
-0.7% -$6.79K 0.19% 107
2020
Q3 		$987K Sell
8,835
-2,114
-19% -$193K 0.18% 115
2020
Q2 		$888K Buy
10,949
+3,540
+48% +$285K 0.16% 121
2020
Q1 		$515K Buy
+7,409
New +$569K 0.1% 166

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Arden Trust's GH Position: Q4 2022 in Review

Arden Trust sold out of Guardant Health (GH) in Q4 2022, closing a stake of 7,515 shares — an estimated $404K sold.

Arden Trust first reported a position in GH in Q1 2020 and held it in 11 quarters. The position peaked at $1.24M in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Arden Trust reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Arden Trust sold 7,515 Guardant Health shares in Q4 2022, an estimated $404K.
  • Arden Trust first reported a position in Guardant Health in Q1 2020 and held it in 11 quarters.
  • Arden Trust's Guardant Health position peaked at $1.24M in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Arden Trust's 13F filing for Q4 2022, filed 20 Jan 2023.